1. Home
  2. STVN vs ALKS Comparison

STVN vs ALKS Comparison

Compare STVN & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$15.88

Market Cap

5.4B

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$33.01

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STVN
ALKS
Founded
1949
1987
Country
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
5.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
STVN
ALKS
Price
$15.88
$33.01
Analyst Decision
Hold
Strong Buy
Analyst Count
2
13
Target Price
$23.75
$42.85
AVG Volume (30 Days)
1.0M
2.0M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
0.40%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.42
N/A
Revenue Next Year
$9.61
$23.22
P/E Ratio
$26.70
$16.31
Revenue Growth
N/A
N/A
52 Week Low
$13.91
$25.17
52 Week High
$28.00
$36.45

Technical Indicators

Market Signals
Indicator
STVN
ALKS
Relative Strength Index (RSI) 40.83 50.93
Support Level $15.43 $33.04
Resistance Level $16.69 $34.27
Average True Range (ATR) 0.99 1.09
MACD 0.19 -0.30
Stochastic Oscillator 60.60 16.61

Price Performance

Historical Comparison
STVN
ALKS

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: